Waters Parkerson & Co’s Novavax NVAX Stock Holding History

Waters Parkerson & Co’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-500	Closed	-$13K	–	169
2018 Q2	$13K	Hold	500	–	–	﹤0.01%	165
2018 Q1	$21K	Hold	500	–	–	﹤0.01%	169
2017 Q4	$12K	Hold	500	–	–	﹤0.01%	173
2017 Q3	$11K	Hold	500	–	–	﹤0.01%	173
2017 Q2	$12K	Buy	+500	New	+$9.81K	﹤0.01%	168

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Waters Parkerson & Co's NVAX Position: Q3 2018 in Review

Waters Parkerson & Co sold out of Novavax (NVAX) in Q3 2018, closing a stake of 500 shares — an estimated $13K sold.

Waters Parkerson & Co first reported a position in NVAX in Q2 2017 and held it in 5 quarters. The position peaked at $21K in Q1 2018. 160 funds tracked by Wall St. Rank hold NVAX as of Q3 2018.

Waters Parkerson & Co reported no remaining Novavax position as of Q3 2018 after selling out during the quarter.
Waters Parkerson & Co sold 500 Novavax shares in Q3 2018, an estimated $13K.
Waters Parkerson & Co first reported a position in Novavax in Q2 2017 and held it in 5 quarters.
Waters Parkerson & Co's Novavax position peaked at $21K in Q1 2018.
160 funds tracked by Wall St. Rank held Novavax as of Q3 2018.

Based on Waters Parkerson & Co's 13F filing for Q3 2018, filed 13 Nov 2018.